Fund Holdings — Atle Fund Management AB

Total Portfolio Value:
$309.69M
Total Bought:
$46.93M
Total Sold:
$34.09M
Net Transaction:
+$12.84M
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and Company(LLY)31,13339,722+8,589$33.46M$26.85M8.67%-$6.61M
Merck & Co., Inc.(MRK)195,76833,853-161,915$20.61M$22.92M7.40%+$2.31M
Thermo Fisher Scientific Inc.(TMO)29,91522,986-6,929$17.33M$14.45M4.67%-$2.88M
BeOne Medicines AGADS(ONC)40,43241,717+1,285$12.28M$12.14M3.92%-$146.5K
Johnson & Johnson(JNJ)092,377+92,377$0$11.94M3.86%+$11.94M
BridgeBio Pharma, Inc.(BBIO)141,296111,363-29,933$10.81M$11.89M3.84%+$1.09M
Vertex Pharmaceuticals Incorporated(VRTX)22,98422,9840$10.42M$11.17M3.61%+$747.9K
AbbVie Inc.(ABBV)108,181108,1810$24.72M$10.39M3.35%-$14.33M
Stryker Corporation(SYK)26,83526,8350$9.43M$9.58M3.09%+$148.0K
Intuitive Surgical, Inc.(ISRG)22,32270,851+48,529$12.64M$9.44M3.05%-$3.20M
Ionis Pharmaceuticals, Inc.(IONS)92,37727,873-64,504$7.31M$9.40M3.03%+$2.09M
Mirum Pharmaceuticals, Inc.(MIRM)89,685195,768+106,083$7.08M$9.40M3.03%+$2.31M
CVS Health Corporation(CVS)106,51823,773-82,745$8.45M$9.27M2.99%+$814.0K
Revolution Medicines, Inc.(RVMD)90,184617,245+527,061$7.18M$9.08M2.93%+$1.89M
Boston Scientific Corporation(BSX)108,68240,432-68,250$10.36M$8.84M2.86%-$1.52M
Amgen Inc.(AMGN)21,90321,9030$7.17M$8.72M2.81%+$1.55M
Edwards Lifesciences Corp0106,518+106,518$0$8.27M2.67%+$8.27M
Alkermes plcSHS(ALKS)242,473242,4730$6.78M$8.24M2.66%+$1.45M
Incyte Corporation(INCY)70,85150,796-20,055$7.00M$7.97M2.57%+$976.2K
Neurocrine Biosciences, Inc.(NBIX)94,79689,685-5,111$13.44M$7.85M2.54%-$5.59M
Gilead Sciences, Inc.(GILD)50,79647,967-2,829$6.23M$7.16M2.31%+$921.8K
Krystal Biotech, Inc.(KRYS)33,85337,579+3,726$8.35M$6.79M2.19%-$1.55M
Cencora Inc23,77323,470-303$8.03M$6.60M2.13%-$1.43M
iRhythm Holdings, Inc.(IRTC)37,57922,322-15,257$6.67M$6.26M2.02%-$408.4K
Insmed Incorporated(INSM)27,87397,438+69,565$4.85M$5.96M1.92%+$1.10M
Newamsterdam Pharma Co Nv
ORDINARY SHARES
197,03694,796-102,240$6.91M$5.51M1.78%-$1.40M
Celcuity Inc.(CELC)41,831141,296+99,465$4.17M$5.14M1.66%+$969.0K
ABIVAX Société AnonymeADS(ABVX)31,59031,5900$4.26M$4.78M1.54%+$523.5K
Cardinal Health, Inc.(CAH)23,470108,682+85,212$4.82M$4.77M1.54%-$54.9K
IDEAYA Biosciences, Inc.(IDYA)97,43831,133-66,305$3.37M$4.01M1.30%+$643.1K
Tango Therapeutics, Inc.(TNGX)029,915+29,915$0$3.63M1.17%+$3.63M
Spyre Therapeutics, Inc.(SYRE)062,735+62,735$0$3.49M1.13%+$3.49M
Disc Medicine, Inc.(IRON)47,967107,255+59,288$3.81M$3.19M1.03%-$620.4K
Compass Therapeutics, Inc.(CMPX)584,33241,831-542,501$3.14M$3.05M0.99%-$86.8K
UnitedHealth Group Incorporated(UNH)14,63614,6360$3.19M$2.77M0.90%-$418.5K
DexCom, Inc.(DXCM)39,722584,332+544,610$2.64M$2.64M0.85%+$3.6K
Bicara Therapeutics Inc111,3631,169,634+1,058,271$1.87M$2.32M0.75%+$441.0K
Soleno Therapeutics Inc62,73590,184+27,449$2.90M$2.21M0.71%-$697.3K
Pyxis Oncology, Inc.(PYXS)617,245197,036-420,209$709.8K$1.62M0.52%+$908.2K
Arcellx Inc
COMMON STOCK
41,7170-41,717$2.72M$0—-$2.72M
Autolus Therapeutics plcADS(AUTL)1,169,6340-1,169,634$2.33M$0—-$2.33M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)107,2550-107,255$873.1K$0—-$873.1K
UFP Technologies, Inc.(UFPT)22,9860-22,986$5.10M$0—-$5.10M
Page 1 of 1
Atle Fund Management AB — 13F Holdings — Q1 2026 | TickerTrail